Searched for
SAMIT MEHTA
Emcure eyes India growth, global deals amid strong demandEmcure Pharmaceuticals is boosting domestic expansion, R&D, and manufacturing. The company is also exploring acquisition opportunities in I...- Is large-scale silver and gold buying by Indians driving the price rise? How it can impact you and what you should doGold and silver prices saw record highs in 2025. Global factors like central bank buying and geopolitical risks drove these surges. Indian ...
- Dhanteras 2025: Despite record high prices, gold keeps its festive glow intactGold prices have surged nearly 39% in 2025, hitting Rs 1,34,800 per 10 grams on Friday ahead of Dhanteras, while silver, after peaking at R...
- Gold brightest on Dhanteras eve: Yellow metal at record ₹1.34 lakh set to impact salesGold prices have reached a new peak just before Dhanteras, affecting festive sales. Jewellers anticipate more lightweight jewellery purchas...
- Emcure Pharma announces price band for Rs 1,952-crore IPO at Rs 960-1,008/share. Check GMP, other detailsEmcure Pharmaceuticals has announced its initial public offering (IPO) with a price band of Rs 960 to Rs 1,008 per equity share. The subscr...
- Make India key node to verify origin of diamonds, Indian officials tell EUAt a meeting in Brussels last month, the Indian trade body, senior government officials and Indian customs officials have told the European...
- Centre to work on pricing to include Gennova mRNA shot in vaccine driveIndia's drug regulator has approved Gennova's mRNA vaccine for restricted use in emergency situations in adults. Samit Mehta, chief operati...
- Covid panel to decide today on inclusion of Gennova's mRNA jab in vaccine driveThe experts will review its data for its use as a standalone vaccine and will also weigh its benefits as a booster shot and take a decision...
- Gemcovac-19: India's first mRNA jab may soon join vaccine driveGennova Biopharmaceuticals submitted the data in the month of April followed by additional data in the month of May. Earlier last month, in...
- NTAGI could decide on mRNA vaccine's inclusion in national drive next weekIndia's drug regulator approved Gennova's mRNA vaccine for restricted use in emergency situations in adults early this week.
- Gennova in talks with govt to price mRNA vaccine competitivelySince Gennova has the manufacturing-at-risk approval, it has already produced 7 million doses that have been released not only by the compa...
- Gennova to finish Phase 2 & 3 trials of its mRNA jab by January 2022The company had submitted the interim Phase-1 clinical trial data to CDSCO, where it tested for safety and immunogenicity.
- Luxe weddings! Private jets, customised in-flight menus, here's how billionaires work on the ultimate doStep into the world of the ultra-lavish bash.
- Bharat beckons lenders: Banks sets their eyes on small towns, villagesThings may be falling in place for small towns and villages which have been credit starved despite the lofty principles of making credit av...
- Meet India’s next generation of women leaders in pharmaThey are not afraid of taking business risks or foraying into newer businesses and have created environment and pushed for HR reforms targe...
- MS Dhoni to sell health drink, energy bars in partnership with Emcure PharmaceuticalsRhiti Sports, a firm closely associated with Indian cricket captain MS Dhoni, is venturing into health food segment in partnership with Pun...
- Budget 2013: Tax concession sought for social sectorSocial sector representatives pitched for tax exemptions and greater involvement of NGOs in implementation of welfare programmes of the gov...
- Banks turn more receptive to MFIs; UBI sanctions Rs 100 crore loan to Bandhan Financial ServicesOf the Rs 30,000 crore MFIs have borrowed from the banking system till date, this is perhaps the most precious Rs 100 crore ever.
- Bengal artists make a splash overseasWorks of emerging and promising Bengal artists are increasingly being exhibited in shows overseas.
Load More
